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Abstract 
 
Objective 
The aim of this study was to estimate the role of transcranial sonography in detecting basal ganglia changes as 
structural biomarkers in migraine.  
Methods  
Transcranial sonography was performed on Aloka prosound α-10. Semiquantitative and planimetric methods 
were applied when basal ganglia changes were detected.  
Comparison between groups was performed by student t test and Spearman's correlation test.  
Results 
We analyzed 30 migraine patients and 30 age/ sex matched controls. 
Substantia nigra hyperechogenicity was detected in 36.7% migraineurs and in 13.3% controls (t test, 
p=0.036888). Hyperechogenic substantia nigra was found in 70% aura patients and in 20% patients without aura 
(p= 0.007384). Mean substantia nigra echogenic size of all migraine patients was 0.16±0.07 cm² and 0.12±0.043 
cm² in controls (t test, p=0.0011). Lentiform nucleus hyperechogenicity was seen in 50% migraine patients and 
13.3% controls (t test, p= 0.002267). Mean lentiform nucleus echogenic size of all migrenous patients was 
0.34±0.08 cm² and in controls 0.20±0.008 cm² (t test, p= 0.0021). Caudate nucleus  hyperechogenicity was found 
in 26.7% migraine patients and  in 6.6% controls ( t test, p= 0.037667).  
Mean frontal horn width in migraine patients was 8.73+/-1.76 mm and in controls 7.10+/-1,71 ( t test, p=0.0006). 
Substantia nigra hyperechogenicity correlated with disease duration (p= 0.05467) and third ventricle width (p= 
0.02976). 
No other differences between migraineurs and controls were found. 
Conclusion 
Althrough there are significant differences in transcranial findings between migraineurs and controls, the overall 
significance of those findings are still to be evaluated.  
 
 
 
 
 
 
Introduction 
 
Migraine is a common, widespread neurological disorder with pathophysiology that is still not fully understood.  
Over the past several years different imaging techniques have been used for detection of structural and functional 
abnormalities in migraine patients like functional magnetic resonance and it's variants, PET and SPECT. Those 
techniques can reveal brain regions responsible for onset and symptoms of migraine attack. They can also 
identify regional structural and functional brain abnormalities in migraineurs [1, 2]. 
Transcranial sonography (TCS) and analysis of brainstem nuclei is widely used method in movement disorders 
[3]. Till now TCS in migraine has been limited only to the blood flow analysis [4]. Recent studies revealed 
activation of basal ganglia neurons  and changes in their volume and functional connectivity with different brain 
areas that affects and possible modulates nociceptive pathways [5, 6]. 
The goal of our study was to emphasize the role of transcranial sonography in detecting changes of basal ganglia 
as structural biomarkers in migraine.  
 
Methods 
 
We analyzed thirty patients who were referred to our outpatient clinic with diagnose of migraine. They 
underwent a TCS of brain parenchyma once at the neurosonology laboratory of our clinic. The informed consent 
was obtained from all participants. 
TCS was performed on Aloka prosound α- 10 with 2-4 MHz transducer, dynamic range 45-55dB and the 
penetration depth of 14-16 cm. First we identified mesencephalon and performed analysis of substantia nigra 
(SN), raphe nuclei (NR) and red nucleus (RN). Estimation of SN echogenicity has been done in planimetric 
manner. For most ultrasound systems the size of SN smaller then 0.20 cm² is considered normal [7].  NR were 
estimated semiquantitatively on the three-point scale using RN as a reference point [8].   At the diencephalic 
plane we estimated the third, contralateral lateral ventricle, lentiform (NL) and caudate (NC) nuclei [picture 1]. 
Hyperechogenicity of those nuclei were measured in the same way like SN [9].  
Comparison between groups was performed by unpaired student t test, chi- square test and Spearman's 
correlation test.  
 
Results: 
 Clinical assessment. Thirty three patients were included in our study but three were immediately excluded 
because of inadequate temporal bone windows. We analyzed 3 males and 27 females, mean age 40.4+/- 11.7 
years, average disease duration was 14.2+/-11.0 years with attack frequency of 3.4+/-2.8 per month. Ten patients 
(33.3%) have migraine aura and 14 (46.7%) have positive family history for migraine. We also analyzed 30 age/ 
sex matched controls (5 males, 25 female, mean age 38.8 +/- 9.9 years).  
Transcranial sonology findings. SN hyperechogenicity was detected in 11/30 migraine patients (36.7%). 
Hyperechogenic SN was found in 7/10 (70%) aura patients and in 4/20 (20%) patients without aura (chi- square 
test, p= 0.007384).   Mean SN echogenic size of all migraine patients was 0.16±0.07 cm². Aura patients had 
mean SN size 0.17±0.07 cm² and patients without aura 0.15±0.07 cm² (t test, p= 0.4550). In control group we 
found 4/30 (13.3%) hyperechogenic SN mean size 0.12±0.043 cm². Compared to migrenours we found 
significant difference in number (t test, p=0.036888) and size of hyperechogenicity (t test, p=0.0011). There was 
no difference in NR and RN between migrenours and controls. LN hyperechogenicity was seen in 15/30 (50%) 
migrenous  and 4/30 (13.3%) in controls (t test, p= 0.002267). Mean LN echogenic size (when measured) of all 
migrenous patients was 0.34±0.08 cm² and in controls 0.20±0.008 cm² (t test, p= 0.0021). Thalamus 
hyperechogenicity was detected as dot-like in 2/30 (6.7%) migrenous patients and in 2/30 controls. Size of 
thalamus hyperechogenicity ranged from 0.28±0.11 cm ² in migrenours and 0.24±0.05 cm² in controls (t test, p= 
0.6582). Caudate nucleus hyperechogenicity was found in 8/30 (26.7%) migraine patients and in 2/30 (6.6%) 
controls (t test, p= 0.037667) with no significant difference in hyperehogenic area size. Normal width of the third 
ventricle was found in all patients and controls (< 7 mm) with no difference between migrenous and controls. 
Normal width of the frontal horn of the lateral ventricles was found in all migraine patients and controls (< 15 
mm). Mean frontal horn width in migraine patients was 8.73+/-1.76 mm and in controls 7.10+/-1.71 (t test, 
p=0.0006) [table]. We investigated correlation of SN echogenic sizes in migraine patients with age (largest size 
of each individual, Spearman correlation, n= 30, rho== 0.21234, p= 0.25995) and disease duration (n= 30, rho= -
0.35521, p= 0.05407). We also found no correlation of SN echogenicity sizes in aura patients and age (n=10, 
rho= -0.04088, p= 0.215) and with disease duration (n=10, rho= -0.16051, p= 0.6578). Moreover, SN size of 
migraine patients with aura correlated with width of the third ventricle (n=10, rho=-0.68221, p= 0.02976). We 
found no correlation between SN echogenicity sizes in all migraine patients and widths of the third ventricle 
(n=30, rho= -0.08699, p= 0.6476), frontal horn of the lateral ventricle (n=30, rho= 0.0691, p= 0.71709). There 
was no correlation of NL, NC and thalamus hyperechogenic areas sizes with patients age, disease duration or 
widths of third ventricle and anterior horn of lateral ventricle. 
Limitation of the study is a relatively small sample. 
 
Conclusion 
Changes of basal ganglia  especially SN hyperechogenicity are well known pathognomonic features of idiopathic 
Parkinson disease [10].  Similar TCS findings may represent overlapping of pathological mechanisms despite 
different clinical representation. Regarding SN we also have to consider involvement of red nucleus which is 
located closely to SN region. Regardless we have to consider that changes of the SN might correspond to an 
increased risk of iPD in migrenous patients. We found hyperechogenicity of SN in 13% of healthy controls that 
is insignificantly higher that in other studies. Hyperechogenicity of NL and NC may correspond to the pain 
pathway damage. We found correlation between SN hyperechogenic size and third ventricle width. Significance 
of those findings is still to be investigated.   
There is a question whether the structural and functional changes of the brain represent the effect of migraine or 
do they predispose the higher vulnerability to the disease.  
This technique can identify structural targets as biomarkers for sub-groups of patients with specific therapeutic 
and possible prophylactic measures. To our knowledge, a report of transcranial sonography basal ganglia 
changes in migraine has not been published previously. Usage of transcranial sonography can serve diagnostic 
and possible prognostic aid in identifying migraine sub-types. 
 
Ethical approval: The study had been approved by the institutional research ethics committee and had been 
performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and it's later 
amendments and are comparable ethical standards.  
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↑↓ echogenicity ( migraine) ↑↓ echogenicity ( controls) p 
SN≥0.21 cm² 
N=11/30 ( 36.7%) 
mean= 0.16±0.07 
N= 4/30 (13.3%) 
mean= 0.12±0.043 
*p(N)= 0.036888 
*p(mean)= 0.0011 
NR (1-3) 
↓NR (1,2) n= 4/30 (13.3%) 
N= 3/30 ( 10%) p(N)=0.687573 
↑NL 
N= 15/30 (50%) 
mean= 0.34± 0.08 
N= 4/30 (13.3%) 
mean= 0.20±0.008 
*p(N)= 0.002267 
*p(mean)= 0.0021 
↑NC 
N= 8/30 
(26.7%) 
mean=0.34±0.07 
 
N= 2/30 (6.6%) 
mean= 0.24±0.042 
*p(N)= 0.037667 
p(mean)= 0.0956 
↑N ruber 
N=1/30 ( 3.3%) 
N= 1/30 (3.3%) p(N)=1 
↑thalamus 
N=2/30 ( 6.7%) 
mean= 0.28±0.11 
N= 2/30 (6.7%) 
mean= 0.24±0.05 
p(N)= 1 
p(mean)= 0.6582 
3th ventricle (mm) 
mean=4.07±1.26 
mean=3.5± 1.07 p(mean)= 0.0657 
Ant. horns of lat.ventricle (mm) 
mean=8.73±1.76 
 
mean= 7.1±1.71 *p(mean)= 0.0006 
↑↓ echogenicity (migraine with 
aura) 
↑↓ echogenicity (migraine without 
aura) 
p 
SN≥0.21 cm² 
N= 7/ 10 (70%) 
mean= 0.17±0.07 
N= 4/20 (20%) 
mean= 0.15±0.07 
*p(N)= 0.007384 
p(mean)= 0.4550 
NR (1-3) 
↓NR (1,2) N= 2/10 ( 20%) 
N= 2/20 ( 10%) p(N)= 0.447521 
↑NL 
N=4/10 (40%) 
mean=0.38±0.05 
N=11/20 (55%) 
mean=0.32±0.08 
p(N)= 0.438578 
p(mean)= 0.1669 
↑NC 
N= 2/10 ( 20%) 
mean= 0.40±0.00 
N= 6/20 (30%) 
mean= 0.32± 0.07 
p(N)= 0.559305 
p(mean)= 0.1951 
↑N ruber 
N=0/10 
N=1/20(5%) p(N)= 0.472021 
↑thalamus 
N= 1/10 ( 10%) 
mean= 0.36±0.00 
N=1/20( 5%) 
mean= 0.20± 0.00 
p(N)= 0.604773 
3th ventricle (mm) 
mean= 3.60±0.97 
mean= 4.30±1.34 p(mean)= 0.1540 
Ant. horns of lat.ventricle (mm) 
mean= 8.50± 2.22 
mean= 8.85±1.53 p(mean)= 0.6619 
 
 
Table 1. Sonographyc correlation of mesencephalic and diancephalic nuclei in migraineurs  and controls and 
migraineurs with and without aura.  
SN= substantia nigra; NR= raphe nuclei; NL= lentiform nuclus; NC= nucleus caudatus; ↑= hyperechogenicity; 
↓= hypoechogenicity. 
 p values< 0.05 considered statistically significant ( student t test, chi-square test) 
 
 
 
 
Fig 1.  Mesencephalic and diencephalic plane. (a) Hyperechogenic substantia niga (thick arrow) and normal 
ehogenicity of raphe nuclei (arrowhead). (b) Normal finding: red nuclei (arrow), nuclei raphe (arrowhead). (c) 
Hyperehogenic lentiform nuclus (arrow), 3th and anterior ventricle enlargement (two sided arrows). (d) Normal 
finding. 
 
 
 
 
 
 
 
